3,5-difluoropyridine-2-sulfonyl chloride
![]() |
- $641.7 - $1197
- Product name: 3,5-difluoropyridine-2-sulfonyl chloride
- CAS: 1261587-79-4
- MF: C5H2ClF2NO2S
- MW: 213.59
- EINECS:
- MDL Number:MFCD18411876
- Synonyms:3,5-difluoropyridine-2-sulfonyl chloride;3,5-difluoro-2-pyridinesulfonyl Chloride;2-Pyridinesulfonyl chloride, 3,5-difluoro-
5 prices
Selected condition:
Brand
- Alichem
- Apolloscientific
- Chemenu
- Crysdot
- Matrix Scientific
Package
- 1g
- ManufacturerAlichem
- Product number1261587794
- Product description3,5-Difluoropyridine-2-sulfonylchloride
- Packaging1g
- Price$641.7
- Updated2021-12-16
- Buy
- ManufacturerApolloscientific
- Product numberPC400562
- Product description3,5-Difluoropyridine-2-sulfonylchloride
- Packaging1g
- Price$708
- Updated2021-12-16
- Buy
- ManufacturerChemenu
- Product numberCM175457
- Product description3,5-Difluoropyridine-2-sulfonylchloride 95%
- Packaging1g
- Price$762
- Updated2021-12-16
- Buy
- ManufacturerCrysdot
- Product numberCD11310159
- Product description3,5-Difluoropyridine-2-sulfonylchloride 95+%
- Packaging1g
- Price$815
- Updated2021-12-16
- Buy
- ManufacturerMatrix Scientific
- Product number118224
- Product description3,5-Difluoropyridine-2-sulfonyl chloride
- Packaging1g
- Price$1197
- Updated2021-12-16
- Buy
Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|
Alichem | 1261587794 | 3,5-Difluoropyridine-2-sulfonylchloride | 1g | $641.7 | 2021-12-16 | Buy |
Apolloscientific | PC400562 | 3,5-Difluoropyridine-2-sulfonylchloride | 1g | $708 | 2021-12-16 | Buy |
Chemenu | CM175457 | 3,5-Difluoropyridine-2-sulfonylchloride 95% | 1g | $762 | 2021-12-16 | Buy |
Crysdot | CD11310159 | 3,5-Difluoropyridine-2-sulfonylchloride 95+% | 1g | $815 | 2021-12-16 | Buy |
Matrix Scientific | 118224 | 3,5-Difluoropyridine-2-sulfonyl chloride | 1g | $1197 | 2021-12-16 | Buy |
Properties
Safety Information
Symbol(GHS): | ||||||||
---|---|---|---|---|---|---|---|---|
Signal word: | ||||||||
Hazard statements: |
|
|||||||
Precautionary statements: |
|